Biogen’s Alzheimer’s drug: What’s the price tag on hope?
World of DTC Marketing
JUNE 1, 2021
Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.” If the drug is approved you can bet that it’s going to carry a huge price tag. Biogen needs a new drug revenue badly.
Let's personalize your content